Let me ask you a question. Do you think there has ever been the situation where some company's management picked the right drug, knew it was going to succeed, and yet still did everything they could to self-enrich and ultimately sell for personal gain whilst diluting and shaking the public ownership to smithereens in order to gain more-for-less ultimate company M&A sale price?
I'm not saying that happened with NWBO, I'm just asking the question generically.
Nobody on this board seems particularly interested the public float might have decreased over the past year by 77 million dollars. I find that interesting.
News 
Market Data 
Discover 
